The role of platelets in tumor growth, wound healing and other angiogenesis disease states The role of platelets in angiogenesis has been appreciated in the past both clinically and pre- clinically. We have recently published evidence that platelets actively sequester angiogenesis stimulators as well as inhibitors, and that there may be a higher organization of these opposing roles within platelet. This higher organization may facilitate the ability of platelets to modify angiogenesis in many angiogenesis-dependent disorders such as wound healing, atherosclerosis, tumor growth, macular degeneration and many others. Since the ability of platelets to enhance wound healing is restricted to intact platelets and does not extend to previously frozen platelets, the process most likely involves a reciprocal interaction between live, fully functional platelet and the wound microenvironment. Unlike other cells, platelets are destroyed by freezing. This proposal will a) characterize the molecular and cellular mechanisms by which platelets sequester and store angiogenesis regulators (Specific Aim 1);b) evaluate the mechanisms of release of these angiogenesis regulators from platelets (Specific Aim 2);c) test the potential therapeutic relevance of strategies designed to selectively release stimulators or inhibitors of angiogenesis from platelets in wound and tumor models (Specific Aim 3). The goal of these studies will be to provide a framework for development of novel targeted therapies for improvement of wound care, as well as for inhibition of tumor growth. It is expected that many agents that modify platelet function, secretion of proteins from platelets, and/or platelet adhesion will be applicable for management pathologic angiogenesis.

Public Health Relevance

Platelets are very important in the formation of the provisional matrix that facilitates the growth of new vessels. This process is evident during physiological angiogenesis (such as wound healing or ovulation), as well as in pathological angiogenesis (such as tumor growth, arthritis, endometriosis, macular degeneration, retinopathy etc.). Exploring the similarities of these processes could be therefore very informative. As we have recently demonstrated, the ability of platelets to up- or down-regulate angiogenesis depending on the tissue needs is attributable to a higher organization of stimulators and inhibitors of angiogenesis within platelets. An improved understanding about this ability to down- regulate angiogenesis during wound healing or about the continued stimulation of angiogenesis in tumor growth is likely to lead to novel therapeutic targets. The immediate goal of our initiative will therefore be to improve the knowledge about the basic mechanisms of platelet-facilitated modulation of angiogenesis in wound healing and tumor growth. The anticipated benefit is that our efforts will lead to discovery of unique molecular targets that could then be studied in clinical trials, and lead to an accelerated improvement in the lives of children and adults, who face death from cancer, or disability due to chronic wounds.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Somers, Scott D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Genesys Research Institute, Inc.
United States
Zip Code
Rietman, Edward A; Platig, John; Tuszynski, Jack A et al. (2016) Thermodynamic measures of cancer: Gibbs free energy and entropy of protein-protein interactions. J Biol Phys 42:339-50
Kareva, Irina (2016) Escape from tumor dormancy and time to angiogenic switch as mitigated by tumor-induced stimulation of stroma. J Theor Biol 395:11-22
Kareva, Irina; Abou-Slaybi, Abdo; Dodd, Oliver et al. (2016) Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition. PLoS One 11:e0166655
Kareva, Irina; Waxman, David J; Lakka Klement, Giannoula (2015) Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. Cancer Lett 358:100-6
Afranie-Sakyi, Jennifer A; Klement, Giannoula Lakka (2015) The toxicity of anti-VEGF agents when coupled with standard chemotherapeutics. Cancer Lett 357:1-7
Rössler, Jochen; Saueressig, Ulrich; Kayser, Gian et al. (2015) Personalized Therapy for Generalized Lymphatic Anomaly/Gorham-Stout Disease With a Combination of Sunitinib and Taxol. J Pediatr Hematol Oncol 37:e481-5
Prochazka, Vaclav; Klosova, Hana; Stetinsky, Jiri et al. (2014) Addition of platelet concentrate to dermo-epidermal skin graft in deep burn trauma reduces scarring and need for revision surgeries. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:242-58
Bencsiková, Beatrix; Greplová, Kristína; Pilátová, Kate?ina et al. (2014) [Platelets in the pathogenesis of solid tumors]. Cas Lek Cesk 153:78-85
Hahnfeldt, Philip; Hlatky, Lynn; Klement, Giannoula Lakka (2013) Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics. Cancer Res 73:2949-54
Pilatova, Katerina; Greplova, Kristina; Demlova, Regina et al. (2013) Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. J Hematol Oncol 6:42

Showing the most recent 10 out of 21 publications